Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Walkingshadow who wrote (315)	6/15/1999 7:47:00 PM
From: scaram(o)uche	Read Replies (1) of 3044

>> So, my interpretation is that MLNM has relinquished the pursuit of anti-obesity compounds to Roche << No. MC4-receptor only. MLNM has other routes to obesity. >> although my understanding is that they would receive royalty or licensing fees for any drug Roche develops and markets as a result---I'm not sure about this, though---anybody know for sure? << This isn't Yahoo. There's a wealth of information in this thread and others........ try reading. Biotech analysis at SI is as good as it gets.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next